The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease | Radiation Oncology | Full Text

The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease | Radiation Oncology | Full Text

The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease

There was no study investigating real-world utilization and outcome of LCT in Osimertinib-treated NSCLC with oligo-residual disease. This study was to analyze the clinical value of local consolidative therapy ...

Authors:Ya Zeng, Jianjiao Ni, Fan Yu, Yue Zhou, Yang Zhao, Shuyan Li, Tiantian Guo, Li Chu, Xi Yang, Xiao Chu, Xuwei Cai and Zhengfei Zhu

Citation:Radiation Oncology 2020 15:207

Content type:Research

 

Published on: 27 August 2020

• ViewFull Text
 
• ViewPDF